
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Human not active centr
- Valdyn (ex Kudeq)

Community Register of medicinal products
Community list of not active medicinal products for human use |
WITHDRAWN |
Product information |
| Invented name: | Valdyn (ex Kudeq) |
| Auth. number : | EU/1/02/244 |
| INN : | Valdecoxib |
| ATC: | M - Musculo-skeletal system M01 - Antiinflammatory and antirheumatic products M01A - Antiinflammatory and antirheumatic products, non-steroids M01AH - Coxibs M01AH03 - Valdecoxib (See WHO ATC Index) |
| Indication: | Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis. Treatment of primary dysmenorrhoea. |
| Marketing Authorisation Holder: | Pfizer Limited
Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom |
EPAR and active package presentations![]()
Package presentations
|
The section of the Community Register "Package presentations" will no longer be updated as from 2 November 2012.
Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information". Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register. |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 31/03/2003 | Centralised - Authorisation | EMEA/H/C/437 | (2003)1135 of 27/03/2003 | |||
| 06/04/2004 | Centralised - Variation | EMEA/H/C/437/IA/6 | ||||
| 06/04/2004 | Centralised - Variation | EMEA/H/C/437/IA/7 | ||||
| 22/04/2004 | Centralised - Variation | EMEA/H/C/437/IB/4 | ||||
| 22/04/2004 | Centralised - Variation | EMEA/H/C/437/IB/5 | ||||
| 27/04/2004 | Centralised - Variation | EMEA/H/C/437/II/3 | (2004)1683 of 22/04/2004 | |||
| 26/07/2004 | Centralised - Variation | EMEA/H/C/437/IB/9 | ||||
| Updated with Decision(2005)239 of 26/01/2005 | ||||||
| 31/01/2005 | Centralised - Variation | EMEA/H/C/437/II/10, 11 | (2005)239 of 26/01/2005 | |||
| 07/06/2005 | Centralised - Variation | EMEA/H/C/437/II/12 | (2005)1746 of 03/06/2005 | |||
| 28/06/2005 | Centralised - Withdrawal | - | (2005)1980 of 24/06/2005 |